We are pleased to announce another milestone in our research efforts. After collecting large blood draws from 100 HIV-1 infected patients by the beginning of May, by the end of 2023 we reached our goal of enrolling 200 patients in our study. The recruitment of patients and the processing of the…

For the first time our team has investigated the longevity of neutralising antibodies in HIV-1-infected individuals. It is currently believed that an HIV-1 vaccine can only be effective if it induces these antibodies in vaccinated individuals. The findings improve the understanding of the dynamics…

In collaboration with the Bloom lab (Fred Hutchinson Cancer Center, Seattle, USA) we have just published "Mapping the Neutralizing Specificity of Human Anti-HIV Serum by Deep Mutational Scanning." In Cell Host Microbe. In this publication the Bloom lab presents a novel deep mutational scanning…

We are thrilled to announce a significant milestone in our research efforts. Our team has successfully collected over 100 large blood draws from HIV-1 infected patients, marking a crucial step forward in our mission to understand the latent reservoir and HIV-1 antibody resistances in these…

Check out our career options. And maybe you would like to join us?

Full Article on pubmed